Inclusive of all taxes
1 Vial(s) Of 16ml
Abevmy 400mg Injection is a targeted cancer therapy used to treat advanced cancers. It works by blocking a protein called VEGF-A, which helps tumors grow new blood vessels. By stopping this process, Abevmy cuts off the tumor’s blood supply, slowing its growth and spread.
Abevmy 400mg Injection is administered by a healthcare professional as an intravenous (IV) infusion. It is typically given once every 2 to 3 weeks, with the dose adjusted according to your body weight.
Inform your medical team immediately if you experience dizziness, nausea, light-headedness, sweating, headache, shortness of breath, or chest pain during the infusion.
Regular medical tests may be required to monitor your response to treatment. Depending on the results, your treatment schedule may be adjusted or delayed.
Abevmy 400mg Injection is not recommended for children and teenagers under 18 years, as its safety and effectiveness have not been confirmed for this age group. In elderly patients (65 years and above), it should be used with caution and only under a doctor’s supervision.
Bevacizumab is a monoclonal antibody that works by blocking vascular endothelial growth factor (VEGF). VEGF is a protein that helps cancer cells form new blood vessels (a process called angiogenesis), which tumors need to grow and spread.
By inhibiting VEGF, Bevacizumab slows or stops the growth of blood vessels that supply tumors, thereby starving the tumor of nutrients and oxygen. This helps slow tumor growth, shrink tumors, and enhance the effectiveness of other cancer treatments.
Side Effects of Abevmy 400mg Injection
Like all medications, Abevmy 400mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
For colorectal cancer, Bevacizumab is given through a drip (IV infusion) along with chemotherapy. The amount depends on the type of chemotherapy used either every 2 weeks at a lower dose or a higher dose. If the cancer comes back or gets worse after the first treatment, it can still be given every 2 or 3 weeks at adjusted doses.
In lung cancer (non-small cell type), the usual dose is given once every 3 weeks together with other chemotherapy medicines like carboplatin and paclitaxel. The treatment is continued as long as it helps and the side effects are manageable.
For brain cancer (glioblastoma), the medicine is usually given once every 2 weeks through an IV infusion. Treatment continues until the cancer worsens or the side effects become too difficult to handle.
Do not breastfeed while taking Abevmy 400mg Injection, and for at least 6 months after the treatment. The medicine can affect your baby’s growth.
It is not clear if drinking alcohol is safe during this treatment. Please check with your doctor before consuming alcohol.
Tell your doctor if you have any lung conditions before beginning this treatment.
Avoid driving or operating machines while on this medicine, as it can cause dizziness or sleepiness.
Do not use Abevmy 400mg Injection if you are pregnant or planning to become pregnant. This medicine can harm your unborn baby and affect the formation of blood vessels.
During your first Abevmy 400mg infusion, a healthcare professional will administer the medicine through a vein and monitor you for infusion-related reactions. You may experience mild fever, chills, or headache. Inform your medical team if you feel uncomfortable.
Abevmy 400mg may take several weeks or treatment cycles to show measurable results. Your oncologist will assess its effectiveness through scans, medical examinations, and other tests during follow-up visits.
Yes. Many patients can continue working during Abevmy treatment, depending on their energy levels and side effects. Taking adequate rest, attending scheduled appointments, and discussing work-related concerns with your doctor can help.
There are no specific food restrictions associated with Abevmy. Most patients can follow their normal balanced diet unless advised otherwise by their doctor. Discuss any supplements or herbal products with your healthcare team.
Abevmy 400mg is not commonly associated with significant hair loss because it is a targeted therapy rather than conventional chemotherapy. However, hair loss may occur when it is combined with certain chemotherapy medicines.
Follow your prescribed treatment plan, stay hydrated, eat balanced meals, and monitor your blood pressure as advised. Report unusual bleeding, severe headaches, chest pain, or breathing difficulties to your doctor immediately.
Coverage for Abevmy 400mg depends on your health insurance policy, cancer treatment benefits, and hospital network. Contact your insurer to confirm eligibility, pre-authorisation requirements, and reimbursement limits before treatment.
Treatment alternatives may include other targeted therapies, chemotherapy, immunotherapy, or different bevaAbevmy brands and biosimilars. The appropriate option depends on your cancer type, stage, and treatment response.
Abevmy 400mg is primarily used for specific cancer treatment settings, including certain advanced or metastatic cancers. Its suitability for early-stage cancer depends on the diagnosis and approved treatment guidelines. Consult your oncologist.
Abevmy 400mg (bevaAbevmy) generally requires refrigeration at 2°C–8°C and protection from light. Do not freeze or shake the vial. Follow the specific manufacturer's storage instructions and consult your pharmacist before transporting or storing it at home.
| Active ingredient | Bevacizumab |
| Pharmacologic class | Monoclonal antibody (anti-VEGF) |
| Medication category | ANTI NEOPLASTICS |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Azadine 100mg Injection contains Azacitidine which belongs to the group of medicines called Anticancer agents. It is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Azadine 100mg Injection is typically used in adults who cannot undergo stem cell transplantation. It may be also used to treat other conditions, as determined by the doctor.
Azadine Injection is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised.
You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.
Azadine 100mg Injection is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
It is used to treat:
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ques 1: What is the use of AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Ques 2: How does AZADINE 100MG INJECTION works?
Ans :AZADINE 100MG INJECTION is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
Ques 3: Can I take AZADINE 100MG INJECTION during breastfeeding?
Ans :No. AZADINE 100MG INJECTION is not recommended for use in breast-feeding women. Therefore, inform your doctor before receiving it.
Ques 4: Can AZADINE 100MG INJECTION increase the risk of infections?
Ans :AZADINE 100MG INJECTION may cause a drop in the number of white blood cells in the body and may weaken your immune system. As a result, you may be at a greater risk of getting infected while receiving AZADINE 100MG INJECTION. To avoid this, your doctor will regular monitor your blood counts as a precaution. However, inform your doctor if you experience any signs of infection such as fever.
Ques 5: Can the use of AZADINE 100MG INJECTION make me feel tired?
Ans :Yes. AZADINE 100MG INJECTION may make you feel tired easily. This is because, it reduces the levels of red blood cells in your blood and may make you anemic. Consult your doctor if you experience tiredness after receiving AZADINE 100MG INJECTION. Tiredness can also occur if you have any pre-existing disease conditions such as liver or kidney impairment while receiving this medicine.
Ques 6: Can I drive a car after receiving AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION may make you feel tired or weak. Therefore, do not drive or operate any heavy tools or machines if your ability is affected by AZADINE 100MG INJECTION.
Ques 7: How AZADINE 100MG INJECTION is administered?
Ans :AZADINE 100MG INJECTION will be given to you only by a doctor or a nurse beneath the skin (subcutaneously) of thighs, arms or abdomen.
Ques 8: How to control nausea caused due to AZADINE 100MG INJECTION?
Ans :Generally, anticancer medicines are associated with uncontrollable nausea and vomiting. To avoid this, your doctor would prescribe a suitable medicine to control them along with AZADINE 100MG INJECTION. If not, consult your doctor for a suitable anti-emetic medicine. Do not self-treat nausea.
Abevmy 400mg Injection is a targeted cancer therapy used to treat advanced cancers. It works by blocking a protein called VEGF-A, which helps tumors grow new blood vessels. By stopping this process, Abevmy cuts off the tumor’s blood supply, slowing its growth and spread.
Abevmy 400mg Injection is administered by a healthcare professional as an intravenous (IV) infusion. It is typically given once every 2 to 3 weeks, with the dose adjusted according to your body weight.
Inform your medical team immediately if you experience dizziness, nausea, light-headedness, sweating, headache, shortness of breath, or chest pain during the infusion.
Regular medical tests may be required to monitor your response to treatment. Depending on the results, your treatment schedule may be adjusted or delayed.
Abevmy 400mg Injection is not recommended for children and teenagers under 18 years, as its safety and effectiveness have not been confirmed for this age group. In elderly patients (65 years and above), it should be used with caution and only under a doctor’s supervision.
Bevacizumab is a monoclonal antibody that works by blocking vascular endothelial growth factor (VEGF). VEGF is a protein that helps cancer cells form new blood vessels (a process called angiogenesis), which tumors need to grow and spread.
By inhibiting VEGF, Bevacizumab slows or stops the growth of blood vessels that supply tumors, thereby starving the tumor of nutrients and oxygen. This helps slow tumor growth, shrink tumors, and enhance the effectiveness of other cancer treatments.
Side Effects of Abevmy 400mg Injection
Like all medications, Abevmy 400mg Injection may cause side effects. However, not everyone will experience them.
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
For colorectal cancer, Bevacizumab is given through a drip (IV infusion) along with chemotherapy. The amount depends on the type of chemotherapy used either every 2 weeks at a lower dose or a higher dose. If the cancer comes back or gets worse after the first treatment, it can still be given every 2 or 3 weeks at adjusted doses.
In lung cancer (non-small cell type), the usual dose is given once every 3 weeks together with other chemotherapy medicines like carboplatin and paclitaxel. The treatment is continued as long as it helps and the side effects are manageable.
For brain cancer (glioblastoma), the medicine is usually given once every 2 weeks through an IV infusion. Treatment continues until the cancer worsens or the side effects become too difficult to handle.
Do not breastfeed while taking Abevmy 400mg Injection, and for at least 6 months after the treatment. The medicine can affect your baby’s growth.
It is not clear if drinking alcohol is safe during this treatment. Please check with your doctor before consuming alcohol.
Tell your doctor if you have any lung conditions before beginning this treatment.
Avoid driving or operating machines while on this medicine, as it can cause dizziness or sleepiness.
Do not use Abevmy 400mg Injection if you are pregnant or planning to become pregnant. This medicine can harm your unborn baby and affect the formation of blood vessels.
During your first Abevmy 400mg infusion, a healthcare professional will administer the medicine through a vein and monitor you for infusion-related reactions. You may experience mild fever, chills, or headache. Inform your medical team if you feel uncomfortable.
Abevmy 400mg may take several weeks or treatment cycles to show measurable results. Your oncologist will assess its effectiveness through scans, medical examinations, and other tests during follow-up visits.
Yes. Many patients can continue working during Abevmy treatment, depending on their energy levels and side effects. Taking adequate rest, attending scheduled appointments, and discussing work-related concerns with your doctor can help.
There are no specific food restrictions associated with Abevmy. Most patients can follow their normal balanced diet unless advised otherwise by their doctor. Discuss any supplements or herbal products with your healthcare team.
Abevmy 400mg is not commonly associated with significant hair loss because it is a targeted therapy rather than conventional chemotherapy. However, hair loss may occur when it is combined with certain chemotherapy medicines.
Follow your prescribed treatment plan, stay hydrated, eat balanced meals, and monitor your blood pressure as advised. Report unusual bleeding, severe headaches, chest pain, or breathing difficulties to your doctor immediately.
Coverage for Abevmy 400mg depends on your health insurance policy, cancer treatment benefits, and hospital network. Contact your insurer to confirm eligibility, pre-authorisation requirements, and reimbursement limits before treatment.
Treatment alternatives may include other targeted therapies, chemotherapy, immunotherapy, or different bevaAbevmy brands and biosimilars. The appropriate option depends on your cancer type, stage, and treatment response.
Abevmy 400mg is primarily used for specific cancer treatment settings, including certain advanced or metastatic cancers. Its suitability for early-stage cancer depends on the diagnosis and approved treatment guidelines. Consult your oncologist.
Abevmy 400mg (bevaAbevmy) generally requires refrigeration at 2°C–8°C and protection from light. Do not freeze or shake the vial. Follow the specific manufacturer's storage instructions and consult your pharmacist before transporting or storing it at home.
| Active ingredient | Bevacizumab |
| Pharmacologic class | Monoclonal antibody (anti-VEGF) |
| Medication category | ANTI NEOPLASTICS |
| Dosage forms | Injection |
The information on the Phoenix Pharmex website is shared for educational purposes only and is not a substitute for professional medical advice or treatment. Always consult a doctor for any health-related questions. Please avoid self diagnosis or delaying medical care based on this content. Our mission is to support informed decisions not replace professional medical guidance.
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
